Functional role of α 1-adrenoceptor subtypes in murine ophthalmic arteries

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 7, 2011, Pages 4795-4799

  Gericke, Adrian ^a   Kordasz, Marcin L ^a   Steege, Andreas ^b   Sanbe, Atsushi ^c   Goloborodko, Evgeny ^a   Vetter, Jan M ^a   Patzak, Andreas ^d   Pfeiffer, Norbert ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPHTHALMIC ARTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASOCONSTRICTION; VIDEO MICROSCOPY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; OPHTHALMIC ARTERY; POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; VASOCONSTRICTION;

EID: 80052390826     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7516     Document Type: Article

References (40)

1. Dimitrova G, Kato S, Yamashita H, et al. Relation between retrobulbar circulation and progression of diabetic retinopathy. Br J Ophthalmol. 2003;87:622-625.
2. Savage HI, Hendrix JW, Peterson DC, Young H, Wilkinson CP. Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45: 4504-4509.
3. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:157-163.
4. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28:34-62.
5. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008;14: 224-233.
6. Garhofer G, Fuchsjager-Mayrl G, Vass C, Pemp B, Hommer A, Schmetterer L. Retrobulbar blood flow velocities in open angle glaucoma and their association with mean arterial blood pressure. Invest Ophthalmol Vis Sci. 2010;51:6652-6657.
7. Ferrari-Dileo G, Davis EB, Anderson DR. Response of retinal vasculature to phenylephrine. Invest Ophthalmol Vis Sci. 1990;31: 1181-1182.
8. Kawarai M, Koss MC. Sympathetic vasoconstriction in the rat anterior choroid is mediated by alpha1-adrenoceptors. Eur J Pharmacol. 1998;363:35-40.
9. Toda M, Okamura T, Ayajiki K, Toda N. Neurogenic vasoconstriction as affected by cholinergic and nitroxidergic nerves in dog ciliary and ophthalmic arteries. Invest Ophthalmol Vis Sci. 1999;40:1753-1760.
10. Koss MC. Effects of sympathetic nerve stimulation on long posterior ciliary artery blood flow in cats. J Ocul Pharmacol Ther. 2002;18:115-125.
11. Ichikawa M, Okada Y, Asai Y, Hara H, Ishii K, Araie M. Effects of topically instilled bunazosin, an alpha1-adrenoceptor antagonist, on constrictions induced by phenylephrine and ET-1 in rabbit retinal arteries. Invest Ophthalmol Vis Sci. 2004;45:4041-4048.
12. Hein P, Michel MC. Signal transduction and regulation: are all alpha1-adrenergic receptor subtypes created equal? Biochem Pharmacol. 2007;73:1097-1106.
13. Koshimizu TA, Tanoue A, Tsujimoto G. Clinical implications from studies of alpha1 adrenergic receptor knockout mice. Biochem Pharmacol. 2007;73:1107-1112.
14. Perez DM. Structure-function of alpha1-adrenergic receptors. Biochem Pharmacol. 2007;73:1051-1062.
15. Cotecchia S. The alpha1-adrenergic receptors: diversity of signaling networks and regulation. J Recept Signal Transduct Res. 2010;30:410-419.
16. Docherty JR. Subtypes of functional alpha1-adrenoceptor. Cell Mol Life Sci. 2010;67:405-417.
17. Graham RM, Perez DM, Hwa J, Piascik MT. alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res. 1996;78:737-749.
18. Hosoda C, Tanoue A, Shibano M, et al. Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice. Br J Pharmacol. 2005;146:456-466.
19. Marti D, Miquel R, Ziani K, et al. Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor. Am J Physiol Heart Circ Physiol. 2005;289:H1923-H1932.
20. Rokosh DG, Simpson PC. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA. 2002;99:9474-9479.
21. Cavalli A, Lattion AL, Hummler E, et al. Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci U S A. 1997;94:11589-11594.
22. Tanoue A, Nasa Y, Koshimizu T, et al. The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest. 2002;109:765-775.
23. 5 muscarinic acetylcholine receptor knockout mice. Invest Ophthalmol Vis Sci. 2009;50:4822-4827.
24. Brunner E, Puri M. Nonparametric methods in factorial designs. Stat Papers. 2001;42:1-52.
25. Daly CJ, Deighan C, McGee A, et al. A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse. Physiol Genomics. 2002;9:85-91.
26. Martinez-Salas SG, Campos-Peralta JM, Pares-Hipolito J, Gallardo-Ortiz IA, Ibarra M, Villalobos-Molina R. Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed. Auton Autacoid Pharmacol. 2007;27:137-142.
27. Methven L, Simpson PC, McGrath JC. Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes. Br J Pharmacol. 2009;158:1663-1675.
28. Turnbull L, McCloskey DT, O'Connell TD, Simpson PC, Baker AJ. Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR. Am J Physiol Heart Circ Physiol. 2003;284:H1104-H1109.
29. Chalothorn D, McCune DF, Edelmann SE, et al. Differential cardiovascular regulatory activities of the alpha 1B-and alpha 1D-adrenoceptor subtypes. J Pharmacol Exp Ther. 2003;305:1045-1053.
30. Zacharia J, Hillier C, Tanoue A, et al. Evidence for involvement of alpha1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice. Br J Pharmacol. 2005;146:942-951.
31. Rudner XL, Berkowitz DE, Booth JV, et al. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation. 1999;100:2336-2343.
32. Jensen BC, Swigart PM, Laden ME, DeMarco T, Hoopes C, Simpson PC. The alpha-1D is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries. J Am Coll Cardiol. 2009;54:1137-1145.
33. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL Jr, Perez DM. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther. 1995;275:1583-1589.
34. Hrometz SL, Edelmann SE, McCune DF, et al. Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther. 1999;290:452-463.
35. Theroux TL, Esbenshade TA, Peavy RD, Minneman KP. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol. 1996;50:1376-1387.
36. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, Piascik MT. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol. 2002;61:1008-1016.
37. 1Dadrenergic receptor is expressed intracellularly and coupled to increases in intracellular calcium and reactive oxygen species in human aortic smooth muscle cells. J Mol Signal. 2008;3:Art. 6.
38. Garcia-Cazarin ML, Smith JL, Clair DK, Piascik MT. The alpha1Dadrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism. Mol Pharmacol. 2008;74:1000-1007.
39. Vecchione C, Fratta L, Rizzoni D, et al. Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation. 2002;105:1700-1707.
40. Zhang H, Cotecchia S, Thomas SA, Tanoue A, Tsujimoto G, Faber JE. Gene deletion of dopamine beta-hydroxylase and alpha1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling. Am J Physiol Heart Circ Physiol. 2004;287: H2106-H2114.